Curevac announces voting results of general meeting

TÜbingen, germany and boston, usa / accesswire / june 19, 2023 / curevac n.v. (nasdaq:cvac), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mrna"), today announced the voting results of the company's annual general meeting.
CVAC Ratings Summary
CVAC Quant Ranking